CSPIA
GOSS icon

Cary Street Partners Investment Advisory’s Gossamer Bio GOSS Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-100
Closed -$83 – 1095
2023
Q3 		$83 Hold
100
– – ﹤0.01% 1850
2023
Q2 		$120 Hold
100
– – ﹤0.01% 1724
2023
Q1 		$126 Hold
100
– – ﹤0.01% 1651
2022
Q4 		$217 Buy
+100
New +$823 ﹤0.01% 1654

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Cary Street Partners Investment Advisory's GOSS Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Gossamer Bio (GOSS) in Q4 2023, closing a stake of 100 shares — an estimated $83 sold.

Cary Street Partners Investment Advisory first reported a position in GOSS in Q4 2022 and held it in 4 quarters. The position peaked at $217 in Q4 2022. 98 funds tracked by Wall St. Rank hold GOSS as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Gossamer Bio position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 100 Gossamer Bio shares in Q4 2023, an estimated $83.
  • Cary Street Partners Investment Advisory first reported a position in Gossamer Bio in Q4 2022 and held it in 4 quarters.
  • Cary Street Partners Investment Advisory's Gossamer Bio position peaked at $217 in Q4 2022.
  • 98 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.